BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26497736)

  • 21. Failed Percutaneous Transcatheter Tricuspid Valve-in-Valve Replacement Caused by Retained Valve Holder.
    Bennett JM; Deegan R; Maltais S; Pretorius M
    Anesth Analg; 2016 Jan; 122(1):34-6. PubMed ID: 26678467
    [No Abstract]   [Full Text] [Related]  

  • 22. Transvenous transcatheter valve-in-valve implantation after bioprosthetic tricuspid valve failure.
    Mortazavi A; Reul RM; Cannizzaro L; Dougherty KG
    Tex Heart Inst J; 2014 Oct; 41(5):507-10. PubMed ID: 25425983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early bioprosthetic valve deterioration after carcinoid plaque deposition.
    Castillo JG; Filsoufi F; Rahmanian PB; Zacks JS; Warner RR; Adams DH
    Ann Thorac Surg; 2009 Jan; 87(1):321. PubMed ID: 19101329
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimally invasive implantation of a Sapien 3 Ultra Valve in a degenerated tricuspid bioprosthesis.
    Ranocchi F; Nicolò F; Russo M; Lio A; Cammardella A; Bergonzini M; Saitto G; Musumeci F
    J Card Surg; 2020 Jun; 35(6):1371-1374. PubMed ID: 32333436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioprosthetic pulmonary and tricuspid valve replacement in carcinoid heart disease from ovarian primary cancer.
    Takahashi H; Okada K; Asano M; Matsumori M; Morimoto Y; Okita Y
    Circ J; 2009 Aug; 73(8):1554-6. PubMed ID: 19139590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter heart valve implantation for failing surgical bioprostheses: technical considerations and evidence for valve-in-valve procedures.
    Mylotte D; Lange R; Martucci G; Piazza N
    Heart; 2013 Jul; 99(13):960-7. PubMed ID: 23406687
    [No Abstract]   [Full Text] [Related]  

  • 27. Transcatheter tricuspid valve replacement with the Edwards SAPIEN valve.
    Kenny D; Hijazi ZM; Walsh KP
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):267-70. PubMed ID: 21766424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image. Tricuspid and pulmonary valve involvement in carcinoid heart disease.
    Ederhy S; Engel F; Cohen A
    Arch Cardiovasc Dis; 2009; 102(6-7):591-2. PubMed ID: 19664582
    [No Abstract]   [Full Text] [Related]  

  • 29. Carcinoid Heart Disease: Early Outcomes after Surgical Valve Replacement in Nine Patients.
    Mujtaba SS; Clark S
    Heart Surg Forum; 2018 Feb; 21(1):E040-E043. PubMed ID: 29485963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double bioprosthetic valve replacement in right-sided carcinoid heart disease.
    Voigt PG; Braun J; Teng OY; Koolbergen DR; Holman E; Bax JJ; Smit VT; Dion RA
    Ann Thorac Surg; 2005 Jun; 79(6):2147-9. PubMed ID: 15919333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical role of imaging navigation and guidance in transcatheter aortic valve implantation.
    Lang P; Peters TM; Kiaii B; Chu MW
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1241-3. PubMed ID: 22401640
    [No Abstract]   [Full Text] [Related]  

  • 32. Tricuspid valve replacement: bioprostheses are preferable.
    Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
    J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open transcatheter tricuspid balloon expandable valve-in-valve implantation for failed bioprosthesis.
    Gerosa G; D'Onofrio A; Tessari C; Pittarello D; Rubino M; Colli A
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):e3-5. PubMed ID: 23587466
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcatheter valve in valve implantation for failed mitral and tricuspid bioprosthesis.
    Cerillo AG; Chiaramonti F; Murzi M; Bevilacqua S; Cerone E; Palmieri C; Del Sarto P; Mariani M; Berti S; Glauber M
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):987-95. PubMed ID: 21538791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease.
    Bhattacharyya S; Burke M; Caplin ME; Davar J
    Eur J Echocardiogr; 2011 Jan; 12(1):E4. PubMed ID: 20729293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What to expect after tricuspid valve replacement? Long-term results.
    Iscan ZH; Vural KM; Bahar I; Mavioglu L; Saritas A
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):296-300. PubMed ID: 17555971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echo rounds: Undiagnosed severe pulmonic regurgitation in a carcinoid patient for tricuspid valve replacement and patent foramen ovale closure.
    Hastie MJ; Souh J; Ju A; Shanewise JS
    Anesth Analg; 2013 Feb; 116(2):300-2. PubMed ID: 23302967
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgical management of carcinoid heart valve disease.
    Castillo JG; Milla F; Adams DH
    Semin Thorac Cardiovasc Surg; 2012; 24(4):254-60. PubMed ID: 23465673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling.
    Connolly HM; Schaff HV; Mullany CJ; Abel MD; Pellikka PA
    Circulation; 2002 Sep; 106(12 Suppl 1):I51-I56. PubMed ID: 12354709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quadruple valve replacement for valve destruction in carcinoid heart disease.
    McAlindon E; Peterson M; Bryan A; Townsend M
    Eur Heart J; 2011 Aug; 32(15):1946. PubMed ID: 21454342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.